Keith A Ching - Pfizer Inc, Pfizer Global Res & Dev

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 89 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Dendritic Cells and T Cells Drive Enhanced Anti-Tumor Efficacy of Triple Type 2 Cytokine and PD1 Antagonism

Alexander Barron,Eleanore Hendrickson,Paola Marcovecchio, James Mcmahon, Katherine Mcgourty, Sara Patti, Kaili Cage, Conglin Fan,Keith Ching,Fang Jin, Thomas Wynn,Christopher Dillon, Richard Gieseck III

JOURNAL OF IMMUNOLOGYno. 1 (2024)

Cited0Views0Bibtex

Supplementary Table 1 from Molecular Predictors of Sensitivity to the Insulin-like Growth Factor 1 Receptor Inhibitor Figitumumab (CP-751,871)

Adam Pavlicek,Maruja E. Lira,Nathan V. Lee,Keith A. Ching,Jingjing Ye,Joan Cao,Scott J. Garza,Kenneth E. Hook,Mark Ozeck,Stephanie T. Shi, Jing Yuan,Xianxian Zheng,Paul A. Rejto,Julie L.C. Kan,James G. Christensen

openalex（2023）

Cited0Views0Bibtex

Supplementary Table 2 from Molecular Predictors of Sensitivity to the Insulin-like Growth Factor 1 Receptor Inhibitor Figitumumab (CP-751,871)

openalex（2023）

Cited0Views0Bibtex

Table S1 from First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas

Ajay K. Gopal,Ronald Levy,Roch Houot,Sandip P. Patel,Leslie Popplewell,Caron Jacobson,Xinmeng J. Mu,Shibing Deng,Keith A. Ching, Ying Chen,Craig B. Davis,Bo Huang,Kolette D. Fly,Aron Thall,Adrian Woolfson,Nancy L. Bartlett

openalex（2023）

Cited0Views0Bibtex

Supplementary Figures 1-13 from PEST Domain Mutations in Notch Receptors Comprise an Oncogenic Driver Segment in Triple-Negative Breast Cancer Sensitive to a Γ-Secretase Inhibitor

Kai Wang,Qin Zhang,Danan Li,Keith Ching,Cathy Zhang,Xianxian Zheng,Mark Ozeck,Stephanie Shi,Xiaorong Li, Hui Wang,Paul Rejto,James Christensen,Peter Olson

openalex（2023）

Cited0Views0Bibtex

Table S2 from First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas

Ajay K. Gopal,Ronald Levy,Roch Houot,Sandip P. Patel,Leslie Popplewell,Caron Jacobson,Xinmeng J. Mu,Shibing Deng,Keith A. Ching,Ying Chen,Craig B. Davis,Bo Huang,Kolette D. Fly,Aron Thall,Adrian Woolfson,Nancy L. Bartlett

openalex（2023）

Cited0Views0Bibtex

Supplementary Table 2 from an Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735

Kenneth E. Hook,Scott J. Garza,Maruja E. Lira,Keith A. Ching,Nathan V. Lee,Joan Cao, Jing Yuan,Jingjing Ye,Mark Ozeck,Stephanie T. Shi,Xianxian Zheng,Paul A. Rejto,Julie L.C. Kan,James G. Christensen,Adam Pavlicek

openalex（2023）

Cited0Views0Bibtex

PEST Domain Mutations in Notch Receptors Comprise an Oncogenic Driver Segment in Triple-Negative Breast Cancer Sensitive to a Γ-Secretase Inhibitor

Kai Wang,Qin Zhang,Danan Li,Keith Ching,Cathy Zhang,Xianxian Zheng,Mark Ozeck,Stephanie Shi,Xiaorong Li, Hui Wang,Paul Rejto,James Christensen,Peter Olson

pubmed（2023）

Cited114Views0WOSBibtex

114

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn